AIM ImmunoTech

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell AIM ImmunoTech and other ETFs, options, and stocks.

About AIM

AIM ImmunoTech, Inc. is a immuno-pharma company, which focuses on the research and development of therapeutics to treat multiple types of cancers, various viruses and immune-deficiency disorders. Its products include Alferon N Injection and Ampligen. 

CEO
Thomas Kenwood Equels
CEOThomas Kenwood Equels
Employees
19
Employees19
Headquarters
Ocala, Florida
HeadquartersOcala, Florida
Founded
1966
Founded1966
Employees
19
Employees19

AIM Key Statistics

Market cap
10.85M
Market cap10.85M
Price-Earnings ratio
-0.11
Price-Earnings ratio-0.11
Dividend yield
Dividend yield
Average volume
102.25M
Average volume102.25M
High today
$0.7881
High today$0.7881
Low today
$0.665
Low today$0.665
Open price
$0.7131
Open price$0.7131
Volume
7.11M
Volume7.11M
52 Week high
$20.35
52 Week high$20.35
52 Week low
$0.21
52 Week low$0.21

Stock Snapshot

As of today, AIM ImmunoTech(AIM) shares are valued at $0.75. The company's market cap stands at 10.85M, with a P/E ratio of -0.11.

On 2026-06-03, AIM ImmunoTech(AIM) stock moved within a range of $0.67 to $0.79. With shares now at $0.75, the stock is trading +12.0% above its intraday low and -5.5% below the session's peak.

Trading activity shows a volume of 7.11M, compared to an average daily volume of 102.25M.

Over the past 52 weeks, AIM ImmunoTech(AIM) stock has traded between a high of $20.35 and a low of $0.21.

Over the past 52 weeks, AIM ImmunoTech(AIM) stock has traded between a high of $20.35 and a low of $0.21.

AIM News

TipRanks 2d
AIM ImmunoTech enrolls final subject in pancreatic cancer development program

AIM ImmunoTech (AIM) announced enrollment of the final subject in its pancreatic cancer development program, barring disqualifying pre-treatment circumstances....

People also own

Based on the portfolios of people who own AIM. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.